Andrew Kunihiro

Dr. Andrew Kunihiro

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Cancer
Verified
Journal Article
Open access
EJElizabeth Jacobs
Elizabeth Jacobs
LKLindsay N. Kohler
Lindsay N. Kohler
AKAndrew Kunihiro
Andrew Kunihiro
Peter JurutkaPeter Jurutka
Peter Jurutka
Over the past two decades, the question of whether vitamin D has a role in cancer incidence, progression, and mortality has been studied in detail. Colorectal, breast, and prostate cancers have been a particular area of focus; together, these three malignancies account for approximately 35% of cancer cases and 20% of cancer deaths in the United States, and as such are a major public health concern. Herein, we review and synthesize the epidemiological research regarding vitamin D, as measured by the biomarker 25-hydroxycholecalciferol [25(OH)D], and the incidence, progression, and mortality of these cancers. Overall, the results of observational studies of the relationship between 25(OH)D and colorectal cancer have revealed a consistent inverse association for incidence and mortality; while for breast cancer, results have generally demonstrated a relationship between higher 25(OH)D and lower risk for progression and mortality. In contrast, randomized, double-blind clinical trials conducted to date have generally failed to support these findings. For prostate cancer, there is no convincing evidence of an association between 25(OH)D and incidence, and inconsistent data for progression and mortality, though results of one open label clinical trial suggest that supplementation with 4000 IU/d of vitamin D3 may inhibit progression of the disease. Nonetheless, until the results of additional ongoing randomized, double-blind clinical trials are reported, it will be difficult to ascertain if vitamin D itself is related to a reduction in risk for some cancer endpoints, or whether high concentrations of the vitamin D biomarker 25(OH)D may instead serve as a marker for an overall beneficial risk factor profile.

20 May 2020 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
RERebecca L. Edwards
Rebecca L. Edwards
PLPaula B. Luis
Paula B. Luis
FNFumie Nakashima
Fumie Nakashima
AKAndrew Kunihiro
Andrew Kunihiro
SPSai-Han Presley
Sai-Han Presley
CSClaus Schneider
Claus Schneider

1 January 2019 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
AKAndrew Kunihiro
Andrew Kunihiro
JBJulia A Brickey
Julia A Brickey
JFJennifer B Frye
Jennifer B Frye
PLPaula Brazao Mendes Luis
Paula Brazao Mendes Luis
CSClaus Schneider
Claus Schneider
JFJanet L. Funk
Janet L. Funk

22 February 2019 in Journal of Natural Products
Verified
Journal Article
Closed access
AKAndrew Kunihiro
Andrew Kunihiro
PLPaula B. Luis
Paula B. Luis
JBJulia A. Brickey
Julia A. Brickey
JFJen B. Frye
Jen B. Frye
HCH.-H. Sherry Chow
H.-H. Sherry Chow
JFJanet L. Funk
Janet L. Funk

21 January 2020 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
PLPaula B. Luis
Paula B. Luis
AKAndrew Kunihiro
Andrew Kunihiro
JFJanet L. Funk
Janet L. Funk
CSClaus Schneider
Claus Schneider

7 June 2020 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
AKAndrew Kunihiro
Andrew Kunihiro
PLPaula B. Luis
Paula B. Luis
JFJennifer B. Frye
Jennifer B. Frye
WCWade Chew
Wade Chew
HCH. H. Chow
H. H. Chow
JFJanet L. Funk
Janet L. Funk